1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Ghost Tree Capital, LLC Buys Immunomedics Inc, Mersana Therapeutics Inc, Verastem Inc, Sells Aerie Pharmaceuticals Inc, Amicus Therapeutics Inc, Blueprint Medicines Corp

New York, NY, based Investment company Ghost Tree Capital, LLC (Current Portfolio) buys Immunomedics Inc, Mersana Therapeutics Inc, Verastem Inc, Zogenix Inc, Xenon Pharmaceuticals Inc, sells Aerie Pharmaceuticals Inc, Amicus Therapeutics Inc, Blueprint Medicines Corp, Sarepta Therapeutics Inc, Iovance Biotherapeutics Inc during the 3-months ended 2020Q1, according to the most recent filings of the investment company, Ghost Tree Capital, LLC. As of 2020Q1, Ghost Tree Capital, LLC owns 45 stocks with a total value of $364 million. These are the details of the buys and sells.

For the details of Ghost Tree Capital, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/ghost+tree+capital%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of Ghost Tree Capital, LLC
  1. SPDR Series Trust S&P Biotech (XBI) - 737,500 shares, 15.71% of the total portfolio.
  2. SPDR S&P 500 (SPY) - 146,700 shares, 10.40% of the total portfolio.
  3. PowerShares QQQ Trust Ser 1 (QQQ) - 174,200 shares, 9.12% of the total portfolio.
  4. SPDR Select Sector Fund - Health Care (XLV) - 244,700 shares, 5.96% of the total portfolio.
  5. Constellation Pharmaceuticals Inc (CNST) - 650,000 shares, 5.62% of the total portfolio. Shares added by 12.95%
New Purchase: Verastem Inc (VSTM)

Ghost Tree Capital, LLC initiated holding in Verastem Inc. The purchase prices were between $1.26 and $3.38, with an estimated average price of $2.07. The stock is now traded at around $1.75. The impact to a portfolio due to this purchase was 1.09%. The holding were 1,500,000 shares as of .

New Purchase: Zogenix Inc (ZGNX)

Ghost Tree Capital, LLC initiated holding in Zogenix Inc. The purchase prices were between $17.8 and $56.59, with an estimated average price of $36.87. The stock is now traded at around $26.30. The impact to a portfolio due to this purchase was 1.02%. The holding were 150,000 shares as of .

New Purchase: Xenon Pharmaceuticals Inc (XENE)

Ghost Tree Capital, LLC initiated holding in Xenon Pharmaceuticals Inc. The purchase prices were between $8.08 and $17.57, with an estimated average price of $14.31. The stock is now traded at around $12.72. The impact to a portfolio due to this purchase was 1.01%. The holding were 325,000 shares as of .

New Purchase: Trillium Therapeutics Inc (TRIL)

Ghost Tree Capital, LLC initiated holding in Trillium Therapeutics Inc. The purchase prices were between $1.03 and $7.22, with an estimated average price of $3.72. The stock is now traded at around $5.89. The impact to a portfolio due to this purchase was 0.92%. The holding were 825,000 shares as of .

New Purchase: Homology Medicines Inc (FIXX)

Ghost Tree Capital, LLC initiated holding in Homology Medicines Inc. The purchase prices were between $12.5 and $22.04, with an estimated average price of $17.1. The stock is now traded at around $12.85. The impact to a portfolio due to this purchase was 0.85%. The holding were 200,000 shares as of .

New Purchase: Avadel Pharmaceuticals PLC (AVDL)

Ghost Tree Capital, LLC initiated holding in Avadel Pharmaceuticals PLC. The purchase prices were between $4.06 and $10.64, with an estimated average price of $7.67. The stock is now traded at around $7.70. The impact to a portfolio due to this purchase was 0.76%. The holding were 350,000 shares as of .

Added: Immunomedics Inc (IMMU)

Ghost Tree Capital, LLC added to a holding in Immunomedics Inc by 110.00%. The purchase prices were between $9.48 and $21.16, with an estimated average price of $16.95. The stock is now traded at around $32.67. The impact to a portfolio due to this purchase was 2.04%. The holding were 1,050,000 shares as of .

Added: Mersana Therapeutics Inc (MRSN)

Ghost Tree Capital, LLC added to a holding in Mersana Therapeutics Inc by 150.00%. The purchase prices were between $4.41 and $9.28, with an estimated average price of $7. The stock is now traded at around $9.91. The impact to a portfolio due to this purchase was 1.93%. The holding were 2,000,000 shares as of .

Added: Selecta Biosciences Inc (SELB)

Ghost Tree Capital, LLC added to a holding in Selecta Biosciences Inc by 50.00%. The purchase prices were between $1.5 and $4.52, with an estimated average price of $3.22. The stock is now traded at around $3.32. The impact to a portfolio due to this purchase was 0.38%. The holding were 1,725,000 shares as of .

Added: TG Therapeutics Inc (TGTX)

Ghost Tree Capital, LLC added to a holding in TG Therapeutics Inc by 217.46%. The purchase prices were between $7.14 and $15.99, with an estimated average price of $12.67. The stock is now traded at around $19.93. The impact to a portfolio due to this purchase was 0.37%. The holding were 200,000 shares as of .

Added: Myovant Sciences Ltd (MYOV)

Ghost Tree Capital, LLC added to a holding in Myovant Sciences Ltd by 30.00%. The purchase prices were between $6.55 and $15.52, with an estimated average price of $11.33. The stock is now traded at around $12.04. The impact to a portfolio due to this purchase was 0.28%. The holding were 585,000 shares as of .

Sold Out: Aerie Pharmaceuticals Inc (AERI)

Ghost Tree Capital, LLC sold out a holding in Aerie Pharmaceuticals Inc. The sale prices were between $11.84 and $25.52, with an estimated average price of $19.12.

Sold Out: Amicus Therapeutics Inc (FOLD)

Ghost Tree Capital, LLC sold out a holding in Amicus Therapeutics Inc. The sale prices were between $6.63 and $11.16, with an estimated average price of $9.55.

Sold Out: Blueprint Medicines Corp (BPMC)

Ghost Tree Capital, LLC sold out a holding in Blueprint Medicines Corp. The sale prices were between $48.11 and $82.22, with an estimated average price of $64.89.

Sold Out: Sarepta Therapeutics Inc (SRPT)

Ghost Tree Capital, LLC sold out a holding in Sarepta Therapeutics Inc. The sale prices were between $82.38 and $131.64, with an estimated average price of $114.91.

Sold Out: DBV Technologies SA (DBVT)

Ghost Tree Capital, LLC sold out a holding in DBV Technologies SA. The sale prices were between $2.33 and $12.98, with an estimated average price of $9.06.

Sold Out: Arqule Inc (ARQL)

Ghost Tree Capital, LLC sold out a holding in Arqule Inc. The sale prices were between $19.96 and $20.04, with an estimated average price of $20.



Here is the complete portfolio of Ghost Tree Capital, LLC. Also check out:

1. Ghost Tree Capital, LLC's Undervalued Stocks
2. Ghost Tree Capital, LLC's Top Growth Companies, and
3. Ghost Tree Capital, LLC's High Yield stocks
4. Stocks that Ghost Tree Capital, LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)